Exploring data connection information from vehicle-to-vehicle (V2V) and vehicle-to-infrastructure (V2I) communications using advanced machine learning approaches, an intelligent transportation system (ITS) can provide better safety services to mitigate the risk of road accidents and improve traffic efficiency. In this work, we propose an end-edge-cloud architecture to deploy machine learning-driven approaches at network edges to predict vehicles' future trajectories, which is further utilized to provide an effective safety message dissemination scheme. With our approach, the traffic safety message will only be disseminated to relevant vehicles that are predicted to pass by accident areas, which can significantly reduce the network data transmission overhead and avoid unnecessary interference. Depending on the vehicle connectivity, our system adaptively chooses vehicle-to-vehicle (V2V) or vehicle-to-infrastructure (V2I) communications to disseminate safety messages. We evaluate the system by using a real-world VANET mobility dataset, and experimental results show that our system outperforms other mechanisms without considering any predicted vehicle trajectory density information.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003146 | PMC |
http://dx.doi.org/10.3390/s22072686 | DOI Listing |
JAMA Netw Open
January 2025
Office of Global and Population Health, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts.
Importance: Caries is the most common chronic childhood disease, with substantial health disparities.
Objective: To test whether parent-targeted oral health text (OHT) messages outperform child wellness text (CWT) messages on pediatric caries increment and oral health behaviors among underserved children attending pediatric well-child visits.
Design, Setting, And Participants: The parallel randomized clinical trial, Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children (iSmile), included participants who were recruited during pediatric medical clinic visits at 4 sites in Boston, Massachusetts, that serve low-income and racially and ethnically diverse (herein, underserved) populations.
Z Evid Fortbild Qual Gesundhwes
December 2024
Institut für Allgemeinmedizin, Medizinische Fakultät, Universität Duisburg-Essen, Essen, Deutschland. Electronic address:
Background: Strategies to counteract the impending and in some places already existing shortage of general practitioners (GPs) are being discussed in Germany. One approach could be to establish interprofessional teams in GP practices by integrating physician assistants (PAs).
Question: Can GPs imagine employing a PA in their practice and if so, under what conditions?
Methods: In March/April 2023, about 5,000 GPs in North Rhine-Westphalia (NRW), who work in a region with a care level of < 100 %, and about 1,000 GPs from Saxony-Anhalt were asked to take part in an online-based survey.
Graefes Arch Clin Exp Ophthalmol
December 2024
Eye Ear Nose and Throat Hospital, Fudan University, XuHui District, No. 19 BaoQing Road, Shanghai, 200031, China.
Purpose: This study aimed to measure the changes in refraction difference value (RDV) in different parts of the retina before and after implantable collamer lenses (ICL) surgery.
Design: Prospective study.
Methods: This study included 40 eyes of 40 patients who underwent ICL implantation for myopia.
Environ Int
December 2024
U.S. Geological Survey, Lawrenceville, NJ, USA.
Background: Humans are primary drivers of environmental-contaminant exposures worldwide, including in drinking-water (DW). In the United States, point-of-use DW (POU-DW) is supplied via private tapwater (TW), public-supply TW, and bottled water (BW). Differences in management, monitoring, and messaging and lack of directly-intercomparable exposure data influence the actual and perceived quality and safety of different DW supplies and directly impact consumer decision-making.
View Article and Find Full Text PDFActa Haematol
December 2024
Background: Recent advancements in cellular therapies, particularly CAR-T and T cell engaging bispecific antibodies have significantly altered the therapeutic landscape for Multiple Myeloma. There are two U.S.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!